Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”

被引：0
|
作者：
Haitang Yang
Sean R. R. Hall
Beibei Sun
Feng Yao
机构：
[1] Shanghai Jiao Tong University,Department of Thoracic Surgery, Shanghai Chest Hospital
[2] Gillies McIndoe Research Institute,Institute for Thoracic Oncology, Shanghai Chest Hospital
[3] Shanghai Jiao Tong University,undefined
来源：
British Journal of Cancer | 2021年 / 124卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1177 / 1178
页数：1
相关论文
共 50 条
  • [1] Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy"
    Yang, Haitang
    Hall, Sean R. R.
    Sun, Beibei
    Yao, Feng
    BRITISH JOURNAL OF CANCER, 2021, 124 (06) : 1177 - 1178
  • [2] Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy"
    White, Michael G.
    Eng, Oliver S.
    BRITISH JOURNAL OF CANCER, 2021, 124 (06) : 1179 - 1180
  • [3] Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
    Michael G. White
    Oliver S. Eng
    British Journal of Cancer, 2021, 124 : 1179 - 1180
  • [4] Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
    White, Michael G.
    Schulte, Jefree J.
    Xue, Lai
    Berger, Yaniv
    Schuitevoerder, Darryl
    Vining, Charles C.
    Kindler, Hedy L.
    Husain, Aliya
    Turaga, Kiran K.
    Eng, Oliver S.
    BRITISH JOURNAL OF CANCER, 2021, 124 (03) : 564 - 566
  • [5] Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
    Michael G. White
    Jefree J. Schulte
    Lai Xue
    Yaniv Berger
    Darryl Schuitevoerder
    Charles C. Vining
    Hedy L. Kindler
    Aliya Husain
    Kiran K. Turaga
    Oliver S. Eng
    British Journal of Cancer, 2021, 124 : 564 - 566
  • [6] Expression of PD-L1 in Malignant Peritoneal Mesothelioma (MPM)
    Gazivoda, V. P.
    Kangas-Dick, A. W.
    Roshal, J.
    Greenbaum, A. A.
    Gall, V. A.
    Langan, R. C.
    Grandhi, M. S.
    Kennedy, T. J.
    August, D. A.
    Minerowicz, C. M.
    Alexander, H. R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S31 - S31
  • [7] Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study
    Gazivoda, Victor P.
    Kangas-Dick, Aaron W.
    Greenbaum, Alissa A.
    Roshal, Joshua
    Chen, Chunxia
    Moore, Dirk F.
    Langan, Russell C.
    Kennedy, Timothy J.
    Minerowicz, Christine
    Alexander, H. Richard
    JOURNAL OF SURGICAL RESEARCH, 2022, 277 : 131 - 137
  • [8] INTRAPERITONEAL CHEMOTHERAPY FOR MALIGNANT PERITONEAL MESOTHELIOMA
    VLASVELD, LT
    GALLEE, MPW
    RODENHUIS, S
    TAAL, BG
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 732 - 734
  • [9] PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1+Lymphocytes within Malignant Effusions Induce PD-L1 Expression
    Khanna, Swati
    Thomas, Anish
    Daga, Daniel Abate
    Morrow, Betsy
    Zhang, Jingli
    Steinberg, Seth M.
    Orlandi, Augusto
    Ferroni, Patrizia
    Schlom, Jeffrey
    Guadagni, Fiorella
    Hassan, Raffit
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S252 - S253
  • [10] Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression. in epithelioid peritoneal malignant mesothelioma: A RENAPE study
    Valmary-Degano, S.
    Colpart, P.
    Villeneuve, L.
    Monnien, F.
    M'Hamdi, L.
    Averous, G. Lang
    Capovilla, M.
    Bibeau, F.
    Laverriere, M. -H.
    Verriele-Beurrier, V.
    Ben Rejeb, H.
    Dartigues, P.
    Hommell-Fontaine, J.
    Gilly, F. -N.
    Isaac, S.
    Mery, E.
    EJSO, 2017, 43 (10): : 1915 - 1923
12345